Fibromyalgia
Glucosamine – key area of research says new review of the evidence
Glucosamine-chondroitin continues to be an important area of research when it comes to osteoarthritis of the knee, hip and hand joints, says a recent review of the literature in Current Opinion in Rheumatology.
Key findings of the evidence published over an 18-month period highlight that there has been a sustained focus on glucosamine-chondroitin as a therapeutic agent in the medical management of osteoarthritis. Continue reading
Complex regional pain syndrome: imaging technique shows brain alterations
People who have complex regional pain syndrome may have decreased thickness of areas of the cortex (the brain’s outer layer of nerve tissue). And they also seem to experience some degree of neurocognitive dysfunction, according to the findings that are published in Pain.
Experts measured cortical thickness to see if there were differences in brain structures between 25 people with complex regional pain syndrome and 25 healthy people. Continue reading
People with fibromyalgia more likely to have irritable bowel syndrome but antidepressants may reduce the risk
The risk of developing irritable bowel syndrome (IBS) seems to be significantly higher in people with fibromyalgia, according to a large study published in Medicine.
Previous studies have shown that fibromyalgia and IBS coexist but these studies were small and lacked long-term follow-up. So experts identified 33,729 people recently diagnosed with fibromyalgia in Taiwan. They wanted to look at the risk factors associated with IBS and fibromyalgia in a large group of people. Continue reading
Fibromyalgia symptoms reduced by low-frequency sound stimulation – new research
Low-frequency sound stimulation was shown to reduce pain and sleep symptoms in a small study of people with fibromyalgia, according to a small study published in Pain Research and Management.
A total of 19 women previously diagnosed with fibromyalgia were asked about their: symptoms; therapies they had tried; medication used; levels of pain, mood and insomnia; and activities of daily living. Continue reading
Immune markers in fluid in the brain and spine give clues into symptoms of chronic fatigue syndrome – and have implications for rheumatoid arthritis
Scientists have discovered a unique pattern of immune molecules in fluid in the brain and spine of people with chronic fatigue syndrome and ME. The findings provide insights into the basis for cognitive dysfunction – brain fog – and new hope for improvements in diagnosis and treatment. Continue reading
